Skip to main content

Table 4 Characteristics of ART in HIV/AIDS patients treated with ART in Guangxi between 2003 and 2019

From: Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy

Variables Total (%) (n = 1860) HR (%)
(n = 218)
non-HR (%) (n = 1642) χ2/Z P
Time between HIV diagnosis and ART initiation (days) (Median, IQR) 18 (8, 64.75) 19 (7, 71.75) 18 (8, 64) −0.119 0.905
ART regimen at ART initiation     0.419
NRTI 15 (0.81) 2 (0.92) 13 (0.79)   
NRTI + NNRTI 1628 (87.53) 186 (85.32) 1442 (87.82)   
NRTI + PI 164 (8.82) 21 (9.63) 143 (8.71)   
NRTI + INSTI 8 (0.43) 0 (0.00) 8 (0.49)   
NNRTI 13 (0.70) 3 (1.38) 10 (0.61)   
NNRTI + PI 23 (1.24) 5 (2.29) 18 (1.10)   
PI 9 (0.48) 1 (0.46) 8 (0.49)   
ART modification     6.577 0.010
Yes 155 (8.33) 28 (12.84) 127 (7.73)   
No 1705 (91.67) 190 (87.16) 1515 (92.27)   
Times of ART modification     0.011
0 1705 (91.67) 190 (87.16) 1515 (92.27)   
1 139 (7.47) 28 (12.84) 111 (6.76)   
2 14 (0.75) 0 (0.00) 14 (0.85)   
3 2 (0.11) 0 (0.00) 2 (0.12)   
ART interruption     0.117
Yes 1 (0.05) 1 (0.46) 0 (0.00)   
No 1859 (99.95) 217 (99.54) 1642 (100.00)   
Cotrimoxazole use during ART     23.136 < 0.001
Yes 506 (27.20) 89 (40.83) 417 (25.40)   
No 1354 (72.80) 129 (59.17) 1225 (74.60)   
Total 1860 (100.00) 218 (11.72) 1642 (88.28)